European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trump’s latest tariff barrage.
Category: Drugs (Pharmaceuticals)
Novo Nordisk’s Woes Are Slimming Denmark’s Economic Growth
Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s growth are falling, too.
Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and consumer-focused market.
South African AIDS Activist Pushes for H.I.V. Treatment Access After U.S.-Aid Cuts
Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S. funding cuts and his own government’s inertia revive old fears.
Explosion at Indian Pharmaceutical Factory Kills 36
It was not immediately clear what led to the blast at a factory near Hyderabad, but officials said initial clues suggested a pressure buildup in a dryer system.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Europe’s Pharma Industry Braces for Pain as Trump Tariff Threat Looms
Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions drag on.
